Pharmagreen Biotech Inc. Stock price OTC Markets
Equities
PHBI
US00922N1046
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0289 USD | -.--% | -4.87% | +172.64% |
Financials (USD)
Sales 2022 | - | Sales 2023 | 0 | Capitalization | 401K |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | - |
Net Debt 2022 | 331K | Net Debt 2023 | 372K | EV / Sales 2023 | 257,842,228 x |
P/E ratio 2022 |
-4.61
x | P/E ratio 2023 |
-0.57
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Wojcik
CEO | Chief Executive Officer | 53 | 13-12-08 |
Terry Kwan
DFI | Director of Finance/CFO | 77 | 15-07-21 |
Ethan Styles
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Wojcik
CEO | Chief Executive Officer | 53 | 13-12-08 |
Terry Kwan
DFI | Director of Finance/CFO | 77 | 15-07-21 |
1st Jan change | Capi. | |
---|---|---|
+9.16% | 45.97B | |
+53.69% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Pharmagreen Biotech Inc.
- Stock Pharmagreen Biotech Inc. - OTC Markets